Edwards spends $1.2B on 2 heart device firms, extending deal streak

Jul 25, 2024  · Edwards Lifesciences said Wednesday it will pay about $1.2 billion to acquire a pair of cardiac device companies that will expand its lineup of structural heart offerings. The …


Install CouponFollow Chrome Extension   CouponFollow Extension

$1
OFF

Edwards Spends $1.2B On 2 Heart Device Firms, Extending Deal Streak

1 day from now

Jul 25, 2024  · Edwards Lifesciences said Wednesday it will pay about $1.2 billion to acquire a pair of cardiac device companies that will expand its lineup of structural heart offerings. The …

medtechdive.com

$1
OFF

Edwards Continues M&A Spree With Genesis’ TAVR Tech

1 day from now

Aug 19, 2024  · Dive Insight: Edwards has been on an acquisition spree. In July, the heart valve specialist said it would pay $1.2 billion to acquire JenaValve Technology, which is also …

medtechdive.com

$1
OFF

Edwards Spends $1.2B On 2 Heart Device Firms, Extending Deal Streak

1 day from now

Jul 25, 2024  · MedTech industry news. Edwards spends $1.2B on 2 heart device firms, extending deal streak . Alongside the acquisitions, Edwards reported a slowdown in its core TAVR …

medicalmore.us

$1
OFF

Edwards Lifesciences Puts Down $1.2 Billion To Expand Structural …

1 day from now

Jul 29, 2024  · The combined upfront purchase price for these acquisitions is approximately $1.2 billion. Edwards expects these investments to solidify its leadership in structural heart …

dotmed.com

$1
OFF

Edwards’ TAVR Sales Faced Ongoing Hospital Constraints In Q3

1 day from now

Oct 25, 2024  · Edwards spends $1.2B on 2 heart device firms, extending deal streak By Susan Kelly • July 25, 2024 Edwards gets Q1 boost as Pascal valve repair sales ramp up By Susan …

medtechdive.com

$1
OFF

Edwards Forecast Fourth-quarter Sales Below Expectations On Soft …

1 day from now

Oct 24, 2024  · In July, the company acquired heart device makers JenaValve Technology and Endotronix in deals valued at $1.2 billion as it looks to cement its position as a pure-play …

reuters.com

$1
OFF

Edwards Lifesciences Is The Big Spender In Medical Devices This Year

1 day from now

Jul 26, 2024  · Edwards Lifesciences is making it rain in July by spending the dog days of summer on dealmaking. The structural heart valve company has dropped over $1.5 billion on upfront …

mddionline.com

$300
OFF

Edwards Win In Valve Device Deal Affirmed By Delaware High Court

1 day from now

Jul 31, 2024  · The Delaware Supreme Court has affirmed Edwards Lifesciences Corp. ‘s victory in investor litigation seeking about $300 million over post-transaction payments tied to its …

bloomberglaw.com

$1
OFF

Edwards Spends $1.2B On 2 Heart Device Firms, Extending Deal Streak

1 day from now

Edwards spends $1.2B on 2 heart device firms, extending deal streak ... Edwards shelled out $1.2 billion to acquire JenaValve Technology and Endotronix, both pioneers in heart valve and heart ...

linkedin.com

$1
OFF

Edwards Spends $1.2B On 2 Heart Device Firms, Extending Deal Streak

1 day from now

Jul 25, 2024  · Edwards spends $1.2B on 2 heart device firms, extending deal streak Leave a Comment / By / 25/07/2024 25/07/2024 Alongside the acquisitions, Edwards reported a …

convitgroup.com

9%
OFF

Edwards Lifesciences Beats Quarterly Estimates On Strong Heart …

1 day from now

Feb 6, 2024  · Transcatheter aortic valve replacement (TAVR) device, Edwards' lead product, which has been facing rising competition from other med-tech peers, posted a 12.9% rise in …

reuters.com

$1
OFF

Edwards Cuts More Than 500 Employees After Critical Care Sale

1 day from now

Sep 5, 2024  · Edwards spends $1.2B on 2 heart device firms, extending deal streak By Susan Kelly • July 25, 2024 BD to buy Edwards’ critical care unit for $4.2B By Ricky Zipp • June 3, 2024

medtechdive.com

$1
OFF

Akim Gaagaa On LinkedIn: Edwards Spends $1.2B On 2 Heart Device …

1 day from now

Edwards Lifesciences spends $1.2B on 2 heart device firms, extending deal streak. Alongside the acquisitions, Edwards reported a slowdown in its core TAVR business in the second quarter …

linkedin.com

$1
OFF

Richard Tey On LinkedIn: Edwards Spends $1.2B On 2 Heart Device …

1 day from now

The deal streak continues with Edwards Lifesciences! Edwards spends $1.2B on 2 heart device firms, extending deal streak medtechdive.com

linkedin.com

$1
OFF

Mehdi Barzegari On LinkedIn: Edwards Spends $1.2B On 2 Heart …

1 day from now

Edwards Lifesciences continue to push forward in the quest to be THE global leader in the @cardiac space. ... $1.2B on 2 heart device firms, extending deal streak ... Abiomed in 2022 …

linkedin.com

FAQs about Edwards spends $1.2B on 2 heart device firms, extending deal streak Coupon?

What is Edwards Lifesciences committed to?

Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. ...

What were the sales of Edwards' TAVR?

Edwards Lifesciences' TAVR device, used for minimally invasive heart surgery, sold $1.03 billion in the quarter, beating analysts' estimates of $974.2 million. ...

Did Edwards Lifesciences beat Wall Street estimates?

Edwards Lifesciences (EW.N) reported fourth-quarter profit on Tuesday that beat Wall Street estimates, helped by strong demand for the company's artificial heart valves and other devices. ...

What does Edwards' acquisition mean for structural heart patients?

Edwards' acquisition will expand its structural heart portfolio to address the large unmet needs of patients suffering from heart failure (HF). Many structural heart patients Edwards serves today also suffer from HF with limited options. ...

How much will Edwards invest in structural heart innovation in 2025?

Edwards anticipates that its strategic investments will strengthen its leadership in structural heart innovation and represent long-term growth opportunities. The aggregate upfront purchase price for these investments is approximately $1.2 billion. Edwards expects minimal revenue contribution from these acquisitions in 2025. ...

Why did Edwards Lifesciences' fourth-quarter sales fall below Wall Street estimates?

Oct 24 (Reuters) - Edwards Lifesciences (EW.N) on Thursday forecast fourth-quarter sales below Wall Street estimates, hurt by softer demand and fierce competition for its artificial heart valves. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension